Covington advised Humacyte on the deal.Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland Capital…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
